Latest articles published - Bartter syndrome
US Approves First RNA Interference Drug
Sep 4, 2018
Alnylam’s Onpattro (patisiran) can treat a rare hereditary disease by silencing a specific gene. The first therapy based on RNA interference (RNAi) gene silencing has been approved by the US Food and...